⚑Today
✨Today's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease🎈For kidsSouth Carolina tract beside wildlife refuge to be permanently conserved🌿NatureFormer ocean liner S.S. United States becomes the world's largest artificial reef⚽SportsLindy Duncan wins her first LPGA title on attempt 222🎨Culture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately HeldπŸ”¬Science & healthPeople who control HIV without treatment may help find a cureπŸ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joinedπŸ›οΈPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressureπŸš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Blocking a cancer enzyme slowed tumours and extended life in mice

Nature 28 October 2026 2 min read

In short

  • Researchers inhibited METTL1, an m7G methyltransferase enzyme, in living mice.
  • Tumour growth was impaired in multiple mouse models of different tissue origin.
  • Survival was substantially prolonged, in studies covering solid and blood cancers.

Why it's good news

The work tested the blocking of METTL1 in living animals, not only in cells. The effect held across cancers that begin in different tissues, both solid and blood. The study is in mice, so human trials would be the next test.

Advertisement

From Nature

Nature, Published online: 28 October 2026; doi:10.1038/s41586-026-11178-z Pharmacological inhibition of the m7G methyltransferase METTL1 in vivo impairs tumour growth and substantially prolongs survival in multiple mouse cancer models of different tissue origin.

Read the full story at Nature Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor